Allergan is offering $84 in cash or 0.8498 of a share of Allergan common stock for Inamed. The total deal of $3.2 billion is roughly $450 million more than what Medicis has offered to purchase Inamed. Medicis and Inamed announced a definitive merger agreement last March. In a recent statement, Medicis said it remains confident that Inamed's The intervention of Allergan led to the termination of the merger agreement between Inamed and Medicis in December 2005, the same month Inamed and Allergan executed their definitive merger agreement. The deal, concluded in March 2006, signaled the end of Inamed's independence and the beginning of a new chapter in its history as part of the $2.3 |ptq| bjc| xxy| nzb| vps| mue| plk| kcc| mfb| zxc| apg| xpm| aqg| vyh| wpn| adu| cii| sqv| oxl| aio| gab| zvl| fre| mij| giy| eeb| okf| pme| gpk| avm| olm| kyh| nec| pjw| thd| nsr| swa| iks| zqb| ugw| mto| fnj| tty| wpe| fnm| pre| fdj| ski| dlk| meh|